News
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).
Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...
U.S. Rep. Bob Latta, R-Bowing Green; Rep. Diana DeGette, D-Colorado; Rep. Dan Crenshaw, R-Texas; and Rep. Debbie Dingell, ...
Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
GoodRx will pay $25 million to settle claims it shared users’ sensitive data with third parties like Meta and Google without ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today provides an update on its commercial and operational ...
Below, check out the roundup of California Healthline's coverage. For today's national health news, read KFF Health News' Morning Briefing.
The Motley Fool. DATE Monday, July 14, 2025 at 5 p.m. EDT CALL PARTICIPANTS Chief Executive Officer -- Shawn O'ConnorChief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results